Assessment of needs in improvement of clinical competences on therapy of dependencies from novel psychoactive substances in the Republic of Kazakhstan

Оценка потребностей в совершенствовании клинических компетенций по терапии зависимостей от новых психоактивных веществ в Республике Казахстан
Mariya Prilutskaya 1, Sergey Molchanov 1
More Detail
1 Pavlodar branch of Semey State Medical University, Department of General Practice and Therapy, Pavlodar, Kazakhstan
J CLIN MED KAZ, Volume 1, Issue 43, pp. 30-33.
OPEN ACCESS 3472 Views 2372 Downloads
Download Full Text (PDF)


Aim of research: assessment of needs in improvement of clinical competences on the topic of novel psychoactive substances (NPS) among specialists of narcological branch.
Methods: cross-sectional study is conducted by means of questionnaire survey of 84 specialists from 3 narcological institutions.
Results: Persons, who have problems with usage of NPS were represented in common structure of patients, who are suffering from substance addictions with frequency of 9,3%. Considering the regular curation of this patients’ group the low level of clinical competences of the third part of respondents is noted on the topic of NPS. Also, incompetent level of knowledge is detected regarding main classes of NPS. Half of respondents (54,8%) are aware of group of synthetic cannabinoids only. Lacked opportunities of education, rare usage of specialized literature, reported by respondents are combined with high demand on new education programs, which include usage of modern information and communication technology: distance education, system of electronic notifcation and information by means of newsletters and letters for private e-mail.
Conclusions: topicality of improvement of competences on topic of NPS is marked, main content of educational programs is determined; forms of continuous information regarding clinical management of cases of NPS abuse are defined.


Prilutskaya M, Molchanov S. Assessment of needs in improvement of clinical competences on therapy of dependencies from novel psychoactive substances in the Republic of Kazakhstan. Journal of Clinical Medicine of Kazakhstan. 2017;1(43):30-3.


  • World Drug Report. United Nations Office on Drugs and Crime. New York, 2014; 51-55.
  • Martinotti G, Lupi M, Carlucci L, Cinosi E, Santacroce R, Acciavatti T, Chillemi E, Bonifaci L, Janiri L, Di Giannantonio M. Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas. Human Psychopharmacology: Clinical and Experimental. 2015; 1;30(4):295-301.
  • Schifano F, Papanti GD, Orsolini L, Corkery JM. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. Expert review of clinical pharmacology. 2016; 2;9(7):943-54.
  • Corazza O, Assi S, Simonato P, Corkery J, Bersani FS, Demetrovics Z, Stair J, Fergus S, Pezzolesi C, Pasinetti M, Deluca P. Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Human Psychopharmacology: Clinical and Experimental. 2013; 1;28(4):317-23.
  • Zawilska JB. Chapter Thirteen-“Legal Highs”–An Emerging Epidemic of Novel Psychoactive Substances. International review of neurobiology. 2015; 31;120:273-300.